Medical composition for treating cardiac wasting and cachexia
AssigneeRELAXERA Pharmazeutische GmbH & Co. KG
InventorThomas Bernd Dschietzig
Life of this patent
Estimating the term…
Abstract
Human relaxin-2 as active ingredient in a pharmaceutical composition for treating a subject suffering from cachexia syndrome or cardiac wasting or suspected of being at risk of suffering from cardiac wasting or cardiac decompensation is described. Also described are methods of diagnosis of cachexia and cardiac wasting and patients suspected of being at risk of suffering from cardiac decompensation. Further described is a patch pump for sc. or iv infusion of relaxin or human relaxin-2.
Claims6
A method of treating a patient diagnosed with cardiac wasting or cardiac cachexia or being at risk of cardiac wasting, comprising the administration of an effective amount of human relaxin-2, wherein said method comprises administering human relaxin-2 at 10 to 100 μg relaxin-2/kg body weight/day.
Dependencies are inferred from the claim text.